TOPLINE: The presence of erosions at diagnosis, longer disease duration, and comorbidities such as fibromyalgia and obesity are associated with the development of difficult-to-treat rheumatoid arthritis […]

TOPLINE: Changes in Krebs von den Lungen 6 (KL-6) levels after 12 months of treatment with mycophenolate mofetil (MMF) or cyclophosphamide (CYC) are associated with the […]

TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic activity with high symptom burden, and low systemic activity […]

TOPLINE: Patients with systemic lupus erythematosus (SLE) face more than double the risk for atherosclerotic plaque progression than healthy control individuals without the condition, but management […]

TOPLINE: Patients with rheumatoid arthritis (RA) face a higher risk for heart failure (HF) than those without the condition, with the elevated risk primarily driven by […]

TOPLINE: Tumor necrosis factor (TNF) inhibitors protect patients with axial spondyloarthritis (axSpA) from hip and spine fractures better than other drugs. METHODOLOGY: Large US insurance claims […]

TOPLINE: Gout patients who take colchicine at the start of urate-lowering therapy have a lower risk for cardiovascular events than those who do not receive prophylaxis. […]

TOPLINE: Stem cell transplantation tames some refractory systemic juvenile idiopathic arthritis–related lung disease that does not respond to other treatment. METHODOLOGY: Retrospective cohort study of 13 […]